Vienna, Austria

Ines Swoboda

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ines Swoboda: Innovator in Allergy Research

Introduction

Ines Swoboda is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of allergy research, particularly in the development of hypoallergenic proteins and methods for identifying allergenic substances. With a total of 4 patents to her name, her work is paving the way for advancements in allergy treatment and prevention.

Latest Patents

Ines Swoboda's latest patents include a vaccine carrier that features a hypoallergenic protein. This innovative protein consists of at least one hypoallergenic molecule derived from an allergen, which is fused or conjugated to a non-allergenic protein or fragment. Another notable patent is a method for identifying allergenic proteins and peptides, specifically targeting milk proteins. This method involves creating an expression library from the mammary gland tissue of lactating cows and determining the binding capacity of proteins to IgE from sensitive individuals.

Career Highlights

Throughout her career, Ines has worked with reputable companies such as Biomay AG and Mead Johnson Nutrition Company. Her experience in these organizations has allowed her to apply her research in practical settings, contributing to the development of products aimed at reducing allergic reactions.

Collaborations

Ines has collaborated with esteemed colleagues in her field, including Rudolf Valenta and Peter Valent. These partnerships have enhanced her research and expanded the impact of her innovations in allergy science.

Conclusion

Ines Swoboda is a trailblazer in allergy research, with her innovative patents and collaborations significantly advancing the understanding and treatment of allergies. Her work continues to inspire future developments in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…